Publicaciones en colaboración con investigadores/as de Hospital Universitario de Canarias (84)

2024

  1. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry

    Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264

  2. Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 10, pp. 1325-1338

  3. Real-time PCR detection of PI*S and PI*Z alleles of SERPINA1 gene using SYBR green

    Gene, Vol. 921

  4. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290

  5. Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU

    Digestive and Liver Disease

2023

  1. Admixture mapping of severe asthma exacerbations in Hispanic/Latino children and youth

    Thorax, Vol. 78, Núm. 3, pp. 233-241

  2. Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations

    Pulmonology

  3. Bacterial Colonization of Microplastics at the Beaches of an Oceanic Island, Tenerife, Canary Islands

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 5

  4. COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 4, pp. 255-260

  5. Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis

    Frontiers in Medicine

  6. Efficacy, Efficiency, and Acceptability of Telemedicine for Inflammatory Bowel Disease Patients' Follow-Up Care during the COVID-19 Pandemic

    Digestive Diseases, Vol. 41, Núm. 4, pp. 574-580

  7. Fluoride Levels in Supply Water from the Canary Islands Region

    Foods, Vol. 12, Núm. 4

  8. Hematological Composite Scores in Patients with Inflammatory Bowel Disease

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  9. Human genetics influences microbiome composition involved in asthma exacerbations despite inhaled corticosteroid treatment

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 3, pp. 799-806.e6

  10. Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients

    Inflammatory bowel diseases, Vol. 29, Núm. 7, pp. 1165-1169

  11. Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series

    Journal of Crohn's & colitis, Vol. 17, Núm. 7, pp. 1097-1102

  12. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety

    American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247

  13. Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease

    International journal of molecular sciences, Vol. 24, Núm. 6

  14. The upper-airway microbiome as a biomarker of asthma exacerbations despite inhaled corticosteroid treatment

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 3, pp. 706-715

2022

  1. Adherence to subcutaneous biologic treatment for inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 5, pp. 335-341